When challenged with a low oxygen environment, known as hypoxia, the body
produces a hormone called erythropoietin (EPO), which then stimulates red
blood cell production to carry more oxygen. Transcription of the gene encoding
EPO is dependent upon the hypoxia-inducible factor (HIF), which is a
transcriptional activator. However, HIF alone is not sufficient to activate
EPO. For example, Wang et al. (2010. PLOS ONE 5:
e10002 showed that HIF recruits another protein called p300 to an enhancer for
the EPO gene. Furthermore, deletion of p300 significantly impaired
transcription of the EPO gene in response to hypoxia. Given that \(\mathrm{p}
300\) is a type of histone acetyl transfer-